Over 47 percent antibiotic formulations used in India in 2019 unapproved: Lancet
More than 47 percent of antibiotic formulations used in India's private sector in 2019 were not approved by the central drug regulator, according to a study published in The Lancet Regional Health Southeast Asia.The research also found that azithromycin 500mg tablet was the most consumed antibiotic formulation (7.6 percent) in India, followed by cefixime 200 mg tablet (6.5 percent) during...
Login or Register to read the full article
More than 47 percent of antibiotic formulations used in India's private sector in 2019 were not approved by the central drug regulator, according to a study published in The Lancet Regional Health Southeast Asia.
The research also found that azithromycin 500mg tablet was the most consumed antibiotic formulation (7.6 percent) in India, followed by cefixime 200 mg tablet (6.5 percent) during the year.
The researchers at Boston University, US, and Public Health Foundation of India, New Delhi, examined the private sector antibiotic use, which contributes to 85-90 percent of the total consumption in India.
For more details, check out the link given below:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd